BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6024299)

  • 1. Metabolism of cyclophosphamide.
    Brock N; Hohorst HJ
    Cancer; 1967 May; 20(5):900-4. PubMed ID: 6024299
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the metabolism of cyclophosphamide.
    Connors TA; Foster AB; Gilsenan AM; Jarman M; Tisdale MJ
    Biochem Pharmacol; 1972 May; 21(9):1373-6. PubMed ID: 4402637
    [No Abstract]   [Full Text] [Related]  

  • 3. [DNA biosynthesis in the liver of animals bearing extra-hepatic tumors: role of DNA polymerase].
    Gómez C; Montañés I; Vicente J
    Rev Clin Esp; 1982 May; 165(3):159-63. PubMed ID: 7134528
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of cyclophosphamide activation.
    Kondo T; Muragishi H
    Gan; 1970 Apr; 61(2):145-51. PubMed ID: 5452403
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor host relations. II. Increase of alpha-ketoglutarate in whole blood and urine and hypoalbuminemia of rats bearing the solid rhabdomyosarcoma BA 1112 and the ascitic or solid forms of Walker-carcinoma 256 and Yoshida-sarcoma.
    Schaur RJ; Schreibmayer W; Semmelrock HJ; Tillian HM; Schauenstein E
    J Cancer Res Clin Oncol; 1979 Apr; 93(3):293-300. PubMed ID: 468891
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thin-layer chromatography studies of lipids in the interstitial fluid and in the homogenate of rat tumors].
    Finke E; Scheid P
    Acta Biol Med Ger; 1973; 30(3):353-63. PubMed ID: 4762321
    [No Abstract]   [Full Text] [Related]  

  • 7. [Absorption in vitro, by malignant cells, of serum proteins of rabbits and agoutis (l-asparaginase) conjugated with fluorescent substances].
    Wanick LR
    Rev Inst Antibiot (Recife); 1971 Jun; 11(1):39-42. PubMed ID: 5161610
    [No Abstract]   [Full Text] [Related]  

  • 8. Aryl-2-halogenoalkylamines. XXV. Derivatives of sulphanilamide designed for selective deposition in neoplastic tissue.
    Calvert N; Connors TA; Ross WC
    Eur J Cancer (1965); 1968 Dec; 4(6):627-35. PubMed ID: 5717959
    [No Abstract]   [Full Text] [Related]  

  • 9. [High voltage electrophoretic determination of asparaginic acid in the intestinal fluid of rat tumors with special reference to a possible neoplasm therapy].
    Hofmann F; Büchner M; Scheid P
    Z Gesamte Inn Med; 1972 Oct; 27(19):853-4. PubMed ID: 4647371
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic efficacy of cyclophosphamide as a function of its metabolism.
    Sladek NE
    Cancer Res; 1972 Mar; 32(3):535-42. PubMed ID: 5061308
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
    Volm M; Mattern J; Wayss K
    Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule binding.
    Donelli MG; Guaitani A; Torti L; Damia G; Corti F; Bianchi M; Tortoreto M; Pantarotto C; Bartosek I
    Oncology; 1986; 43(4):257-63. PubMed ID: 3725287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of dietary deficiencies of magnesium and potassium on the growth and chemistry of transplanted tumours and host tissues in the rat.
    Young GA; Parsons FM
    Eur J Cancer (1965); 1977 Feb; 13(2):103-13. PubMed ID: 852485
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro testing of cyclophosphamide on tumors.
    Kaufmann M; Mattern J; Volm M; Hohorst HJ; Peter G; Vollcker G
    Naturwissenschaften; 1975 Sep; 62(9):446-7. PubMed ID: 1186909
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences of cyclophosphamide and 6-mercaptopurine metabolic rates in perfused liver of normal and tumour-bearing animals.
    Bartosek I; Donelli MG; Guaitani A; Colombo T; Russo R; Garattini S
    Biochem Pharmacol; 1975 Jan; 24(2):289-90. PubMed ID: 1111539
    [No Abstract]   [Full Text] [Related]  

  • 16. PRECLINICAL STUDIES FOR THE CHARACTERISATION OF NEW ANTICANCER AGENTS IN ANIMAL EXPERIMENTS.
    BROCK N
    Acta Unio Int Contra Cancrum; 1964; 20():45-7. PubMed ID: 14151959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
    Schneider R
    Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies of soluble organic proteins from tumor- and normal tissues using free electrophoresis].
    Schwenke KD
    Z Krebsforsch; 1966; 68(1):112-9. PubMed ID: 4293739
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble and particle-bound hexokinase in normal and tumour tissues of rats.
    Sydow G
    Acta Biol Med Ger; 1967; 18(3):K1-5. PubMed ID: 4298861
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the effect of whole body warming on the concentration of cyclophosphamide in tumor and normal tissue].
    Kirsch R; Schmidt D; Gabsch HC; Hohaus B
    Z Gesamte Exp Med Einschl Exp Chir; 1968; 145(1):41-56. PubMed ID: 5670246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.